In this episode, we will focus on the changes in management approaches in Inflammatory Bowel Disease (IBD) with a focus on earlier optimal intervention following appropriate risk stratification. Joining us are renowned gastroenterologists, who will share with you their perspectives on the following topics and what clinicians need to do in improving patient care and outcomes.
- Management of IBD as a chronic disease- Dr. David Rubin, Joseph B. Kirsner Professor of Medicine, Section Chief of Gastroenterology, Hepatology and Nutrition and Co-Director of Digestive Diseases Center at the University of Chicago Medicine,
- Optimal approaches in aggressive IBD; key lessons from pediatric Crohn's - Dr. Marla Dubinsky, Chief Pediatric GI and Hepatology, Co-Director of Susan & Leonard Feinstein IBD Clinic at Icahn School of Medicine, Mount Sinai Hospital, NY
- Early treatment and disease modification - Dr. Jean-Fred Colombel, Professor of Medicine at Icahn School of Medicine, Mount Sinai Hospital, NY,
- IBD: The necessity for tight control - Dr. Remo Panaccione, Associate Professor, Department of Medicine, Director of Inflammatory Bowel Disease Clinic, and Director of Gastroenterology Training Program at The University of Calgary.
This module is intended for United States and Puerto Rico health care professionals only and was developed by Abbvie.